Riskpilot← Back to searchSign inGet full access4X4 MEDICINE AS
ASActiveOrg 812197142Brænnes Veg 9B, 7022 TrondheimOther education n.e.c. · NACE 8559Est. 20131 employees
Revenue 2025
NOK 389K
-59% vs 2024
EBITDA margin
-1.5%
-101% vs 2024
Equity ratio
90.8%
Financial strength
Net profit 2025
NOK 837K
-80% vs 2024
| Revenue | NOK 389K | -59% |
| EBITDA | NOK -6K | -101% |
| Net profit | NOK 837K | -80% |
| Total assets | NOK 5M | -5% |
| Equity | NOK 4,5M | +11% |
| Employees | 1 | — |
Legal name
4X4 MEDICINE AS
Org number
812197142
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
10. juli 2013
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Undervisning, medisinsk radgåvning, eierskap i andre relaterte selskap. Eierskap i eiendom relatert til selskapets virksomhet.
Address
Brænnes Veg 9B, 7022 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 765 | 695 | 679 | 956 | 389 |
| Staff expenses | −3 | −9 | −15 | −13 | −23 |
| EBITDA | 455 | 257 | 202 | 564 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 455 | 257 | 202 | 564 | −6 |
| Net financials | 771 | −27 | 20 | 3 853 | 894 |
| Profit before tax | 1 226 | 231 | 221 | 4 417 | 889 |
| Tax | 143 | 52 | 50 | 136 | 51 |
| Net profit | 1 083 | 179 | 172 | 4 281 | 837 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 375 | 2 636 | 1 475 | 5 240 | 4 958 |
| Equity | 1 473 | 1 652 | 782 | 4 063 | 4 501 |
| Long-term debt | 677 | 658 | 0 | 0 | 0 |
| Short-term debt | 225 | 327 | 693 | 1 177 | 457 |
| Total debt | 902 | 985 | 693 | 1 177 | 457 |
EBITDA margin
-1.5%
This company
15.8%
Market median
-109% vs market
20212025
Equity ratio
90.8%
This company
38.2%
Market median
+138% vs market
20212025
Return on equity
18.6%
This company
18.4%
Market median
+1% vs market
20212025
Net profit margin
215.3%
This company
8.1%
Market median
+2558% vs market
20212025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2013 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
4X4 MEDICINE AS (this company)
TRENHER ASBoard members of 4X4 MEDICINE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Hoff | Chief Executive Officer | 0 companies |
| Jan Helgerud | Chief Executive Officer | 0 companies |